Select Page

The global top 10 bioprocess technology market is expected to reach USD 71.03 Billion by 2021 from USD 39.30 Billion in 2016, at a CAGR of 12.4% from 2016 to 2021. Rapid growth in pharmaceutical and biotechnology industries, growth in the number of new drug launches, strong trend of R&D in life sciences research, increasing government support for pharmaceutical and biotechnology industries, and rising prevalence of chronic diseases are the key factors driving the growth of this market.
Target audience for this report:

# Academic Research Institutes
# Pharmaceutical Companies
# Biotechnology Companies
# Bioprocess Technology Manufacturing Companies
# Contract Research Organizations (CROs)
# Market Research & Consulting Firms
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=30722776

The report provides an overall understanding of the global Top 10 Bioprocess Technologies Market. It segments the global market on the basis of type and region. On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, cell line development, flow cytometry, single-use bioprocessing, biologics safety testing, virus filtration, tangential flow filtration, and pyrogen testing.

In 2016, the cell culture segment is expected to account for the largest share of the global top 10 bioprocess technology market. The largest share of this segment is primarily attributed to the repeated purchase of consumables as compared to equipment and increase in funding for cell-based research.

On the basis of region, the Top 10 Bioprocess Technologies Market is segmented into North America, Europe, Asia, and RoW. The report maps each bioprocess technology in these geographic and regional segments. In 2016, North America is expected to account for the largest share of the global top 10 bioprocess technology market.

Growth in this market can be attributed to the increase in demand of high quality biologics and rising spending on R&D by top players in this region. Similarly, Asia is estimated to grow at the highest CAGR during the forecast period. The wide applications of bioprocess technology in the biopharmaceutical and pharmaceutical industry are expected to drive the demand for top 10 bioprocess technology market in this region.

Top 10 bioprocess technology market is dominated by GE Healthcare (U.S.), Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), and Danaher Corporation (U.S.)

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=30722776

Other prominent players in the Top 10 Bioprocess Technologies Market include Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc.(U.S.), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.).

An analysis of the market developments between 2014 and 2016 revealed that product launches and agreements & collaborations was the most important growth strategy adopted by market leaders.

The other important growth strategy adopted by players in Top 10 Bioprocess Technology Market was mergers & acquisitions, expansions, and product approvals. This strategy was adopted by market players to enhance their product portfolio and geographic presence. Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Merck Millipore (Germany), and Thermo Fisher Scientific, Inc. (U.S.) are some of the companies that adopted this strategy.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com